BC-1471
CAS No. 896683-78-6
BC-1471 ( —— )
Catalog No. M22992 CAS No. 896683-78-6
BC-1471 is a novel selective antagonist of deubiquitinase STAM-binding protein (STAMBP), decreasing NALP7 protein levels and suppressing IL-1β release after TLR agonism.A small-molecule inhibitor of STAMBP deubiquitinase activity, BC-1471, decreases NALP7 protein levels and suppresses IL-1β release after TLR agonism.?
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 147 | Get Quote |
|
10MG | 237 | Get Quote |
|
25MG | 507 | Get Quote |
|
50MG | 731 | Get Quote |
|
100MG | 1017 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBC-1471
-
NoteResearch use only, not for human use.
-
Brief DescriptionBC-1471 is a novel selective antagonist of deubiquitinase STAM-binding protein (STAMBP), decreasing NALP7 protein levels and suppressing IL-1β release after TLR agonism.A small-molecule inhibitor of STAMBP deubiquitinase activity, BC-1471, decreases NALP7 protein levels and suppresses IL-1β release after TLR agonism.?
-
DescriptionBC-1471 is a novel selective antagonist of deubiquitinase STAM-binding protein (STAMBP), decreasing NALP7 protein levels and suppressing IL-1β release after TLR agonism.A small-molecule inhibitor of STAMBP deubiquitinase activity, BC-1471, decreases NALP7 protein levels and suppresses IL-1β release after TLR agonism.?These findings describe a unique pathway of inflammasome regulation with the identification of STAMBP as a potential therapeutic target to reduce pro-inflammatory stress.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptordeubiquitinase STAM-binding protein (STAMBP)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number896683-78-6
-
Formula Weight504.6
-
Molecular FormulaC27H28N4O4S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NCC1=CC=CO1)CSC(N2CCC3=CC=CC=C3)=NC4=C(C=C(N5CCOCC5)C=C4)C2=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Joseph S Bednash, Nathaniel Weathington, James Londino.Targeting the deubiquitinase STAMBP inhibits NALP7 inflammasome activity.Nat Commun. 2017 May 11;8:15203.
molnova catalog
related products
-
Rilmenidine Phosphat...
Rilmenidine Phosphate is a selective I(1) imidazoline receptor agonist, used to treat hypertension.
-
Pinocembrin 7-O-(4,6...
The herbs of Lindera strychnifolia.
-
Nolatrexed dihydroch...
Nolatrexed Dihydrochloride is the dihydrochloride salt of nolatrexed, a water-soluble lipophilic quinazoline folate analog with antineoplastic activity.